Terminal complement complexes (SC5b-9) in cerebrospinal fluid in autoimmune nervous system diseases.
Sanders
M E
ME
National Institutes of Health, Bethesda, Maryland.
Alexander
E L
EL
Koski
C L
CL
Shin
M L
ML
Sano
Y
Y
Frank
M M
MM
Joiner
K A
KA
D001327:Autoimmune Diseases / Q000134:cerebrospinal fluid* / Q000276:immunology; D003186:Complement C9 / Q000276:immunology; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins / Q000134:cerebrospinal fluid* / Q000276:immunology; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D009103:Multiple Sclerosis / Q000134:cerebrospinal fluid* / Q000276:immunology; D011129:Polyradiculoneuropathy / Q000134:cerebrospinal fluid* / Q000276:immunology; D012859:Sjogren's Syndrome / Q000134:cerebrospinal fluid* / Q000276:immunology
D003186:Complement C9; D015938:Complement Membrane Attack Complex; D003165:Complement System Proteins